Kiora Pharmaceuticals furnishes updated investor presentation for H.C. Wainwright conference

KIORA PHARMACEUTICALS INC

Filed 8-K on August 13, 2025 to disclose updated investor presentation (Exhibit 99.1).
Presentation prepared for H.C. Wainwright 5th Annual Ophthalmology Virtual Conference.
Company CFO Melissa Tosca signed the report as principal financial officer.
Data presented under Item 7.01 Regulation FD and not deemed filed for Exchange Act purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.